| Literature DB >> 32371568 |
Jeremiah Chikovore1, Madhukar Pai2, Katherine Chisholm Horton3,4, Amrita Daftary5,6, Moses Kelly Kumwenda7, Graham Hart8, Elizabeth Lucy Corbett3,7.
Abstract
Tuberculosis (TB) is treatable but is the leading infectious cause of death worldwide, with men over-represented in some key aspects of the disease burden. Men's TB epidemiological scenario occurs within a wider public health and historical context, including their prior sidelining in health discussions. Differences are however noticeable in how some Western countries and high TB and HIV burden low and middle-income countries (LMIC) including in Africa have approached the subject(s) of men and health. The former have a comparatively long history of scholarship, and lately are implementing actions targeting men's health and wellness, both increasingly addressing multilevel social and structural determinants. In contrast, in the latter men have received attention primarily for their sexual practices and role in HIV and AIDS and gender-based violence; moreover, interventions, guided by the public health approach, have stressed short-term, measurable and medical goals. Debates and the limited available empirical literature on men's engagement with TB-related healthcare are nevertheless indicating need for a shift, within TB work with men in high burden LMICs towards, structural and multicomponent interventions. © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY. Published by BMJ.Entities:
Keywords: epidemiology; health policies and all other topics; health services research; public health; tuberculosis
Mesh:
Year: 2020 PMID: 32371568 PMCID: PMC7223013 DOI: 10.1136/bmjgh-2019-002255
Source DB: PubMed Journal: BMJ Glob Health ISSN: 2059-7908
M:F sex ratios for incidence, notification and prevalence in selected regions and countries, and from analysis of surveys from different parts of the world; and contributions by sex to global TB notifications, cases and deaths
| Sex ratios for incidence, notification and prevalence in selected regions/countries | |
| WHO Eastern Mediterranean Region | 1.3* |
| WHO European Region | 2.0† |
| WHO West Pacific Region | 2.0† |
| Global | 1.7 |
| WHO Eastern Mediterranean Region | 1.1* |
| WHO West Pacific Region | 2.6† |
| Bacteriologically confirmed TB | 2.21 |
| Smear-positive TB | 2.51 |
Source of data, except ‡: WHO.1
*Lower value among WHO reporting regions
†Upper value among WHO reporting regions
‡Source of data.2
M:F, male-to-female; TB, tuberculosis.